Source:http://linkedlifedata.com/resource/pubmed/id/21789897
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2011-7-27
|
pubmed:abstractText |
Many articles have reported the caveolin-1 gene to be down-regulated thus suggesting that it might be a candidate tumor suppressor gene in many tumors. However, its involvement in bladder cancer is not clear and may be depending on pathological grade. In this case-control study, the association of Cav-1 polymorphisms with bladder cancer risk in a central Taiwanese population was investigated. Three hundred and seventy-five patients with bladder cancer and the same number of age- and gender-matched healthy controls were genotyped. There were significant differences between bladder cancer and control groups in the distributions of their genotypes (P = 1.0 x 10(-12) and 0.299) and allelic frequencies (P = 1.4 x 10(-14) and 6.2 x 10(-3)) in the Cav-1 G14713A (rs3807987) and T29107A (rs7804372) polymorphisms, respectively. As for haplotype analysis, subjects who had GG/AT or GG/AA at Cav-1 G14713A/T29107A showed a decreased risk of bladder cancer compared to subjects with GG/TT, while those of any other combinations were of increased risk. There were joint effects of Cav-1 G14713A and T29107A genotypes with smoking status on individual bladder cancer susceptibility. This is the first report providing evidence that Cav-1 was involved in bladder cancer in that the A allele of the Cav-1 G14713A is risky, the A allele of the Cav-1 T29107A is protective, and AA/TT on these two polymorphisms may be the most risky haplotype for the development of bladder cancer and may be novel useful genomic markers for early detection of bladder cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0304-4920
|
pubmed:author |
pubmed-author:BauDa-TianDT,
pubmed-author:ChangChao-HsiangCH,
pubmed-author:ChenYueh-ShengYS,
pubmed-author:HuangChih-YangCY,
pubmed-author:ShyueSong-KunSK,
pubmed-author:TsaiChia-WenCW,
pubmed-author:TsaiRu-YinRY,
pubmed-author:WangHwei-ChungHC,
pubmed-author:WangRou-FenRF,
pubmed-author:YaoChun-HsuCH
|
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
153-60
|
pubmed:meshHeading |
pubmed-meshheading:21789897-Alleles,
pubmed-meshheading:21789897-Asian Continental Ancestry Group,
pubmed-meshheading:21789897-Case-Control Studies,
pubmed-meshheading:21789897-Caveolin 1,
pubmed-meshheading:21789897-Female,
pubmed-meshheading:21789897-Gene Frequency,
pubmed-meshheading:21789897-Genetic Predisposition to Disease,
pubmed-meshheading:21789897-Genotype,
pubmed-meshheading:21789897-Haplotypes,
pubmed-meshheading:21789897-Humans,
pubmed-meshheading:21789897-Male,
pubmed-meshheading:21789897-Middle Aged,
pubmed-meshheading:21789897-Polymorphism, Single Nucleotide,
pubmed-meshheading:21789897-Risk Factors,
pubmed-meshheading:21789897-Taiwan,
pubmed-meshheading:21789897-Urinary Bladder Neoplasms
|
pubmed:year |
2011
|
pubmed:articleTitle |
Significant association of caveolin-1 genotypes with bladder cancer susceptibility in Taiwan.
|
pubmed:affiliation |
Department of Urology, China Medical University Hospital, Taichung, Taiwan, Republic of China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|